Hospital Acquired Disease Testing Market Size To Hit US$ 27.7 Billion By 2028 | CAGR 17.57%
IMARC Group has recently released a new research study titled " Hospital Acquired Disease Testing Market: Global Industry Trends, Share, Size, Growth, Opportunity and Forecast 2023-2028 ", The global hospital acquired disease testing market size reached US$ 10.3 Billion in 2022. Looking forward, IMARC Group expects the market to reach US$ 27.7 Billion by 2028, exhibiting a growth rate (CAGR) of 17.57% during 2023-2028. This report can serve as an excellent guide for investors, researchers, consultants, marketing strategists and all those who are planning to foray into the market in any form. Hospital acquired disease, or nosocomial infection, is a name given to ailments that are caused by infectious toxin agents in hospitals and medical clinics. They can be categorized into urinary tract infection (UTI), bloodstream infections, surgical site infection (SSI), pneumonia, methicillin-resistant staphylococcus aureus (MRSA), etc. Some of the common reasons behind these types of ho...